Provided by Tiger Trade Technology Pte. Ltd.

Emergent BioSolutions

8.08
-0.1300-1.58%
Post-market: 8.01-0.0651-0.81%18:57 EDT
Volume:927.91K
Turnover:7.51M
Market Cap:418.31M
PE:8.69
High:8.43
Open:8.21
Low:8.01
Close:8.21
52wk High:14.06
52wk Low:4.02
Shares:51.77M
Float Shares:51.26M
Volume Ratio:0.89
T/O Rate:1.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9300
EPS(LYR):0.9300
ROE:10.46%
ROA:5.34%
PB:0.80
PE(LYR):8.69

Loading ...

Aptevo Therapeutics reports third-quarter net loss of $7.5 million

Reuters
·
Nov 06, 2025

Aptevo Therapeutics Inc expected to post a loss of $2.09 a share - Earnings Preview

Reuters
·
Nov 03, 2025

Stock Track | Emergent BioSolutions Plummets 5.22% as One-Off Charge and Gloomy Outlook Weigh on Investor Sentiment

Stock Track
·
Oct 31, 2025

Stock Track | Emergent BioSolutions Plummets 5.22% as One-Off Charge and Gloomy Forecasts Overshadow Profitability

Stock Track
·
Oct 31, 2025

Emergent BioSolutions: Strong Financial Performance and Strategic Positioning Drive Buy Rating

TIPRANKS
·
Oct 31, 2025

Emergent BioSolutions (EBS): One-Off $42.1M Loss Clouds Return to Profit, Tests Bullish Narratives

Simply Wall St.
·
Oct 31, 2025

Emergent BioSolutions’ Earnings Call Highlights Strong Growth

TIPRANKS
·
Oct 31, 2025

Emergent BioSolutions Q3 2025 Earnings Call Summary and Q&A Highlights: Strong Performance and Strategic Growth

Earnings Call
·
Oct 31, 2025

Emergent BioSolutions (EBS) Earnings Transcript

Motley Fool Transcribing
·
Oct 31, 2025

Emergent BioSolutions Up Over 37%, On Track for Highest Close Since July 2024 -- Data Talk

Dow Jones
·
Oct 31, 2025

Stock Track | Emergent BioSolutions Soars 23.40% on Strong Q3 Results and Raised Full-Year Guidance

Stock Track
·
Oct 30, 2025

Emergent BioSolutions Shares Jump 16.6% After Q3 Revenue Beat

THOMSON REUTERS
·
Oct 30, 2025

Stock Track | Emergent BioSolutions Surges 16.49% Pre-market on Strong Q3 Results and Raised Guidance

Stock Track
·
Oct 30, 2025

Stock Track | Emergent BioSolutions Soars 16.49% Pre-market on Strong Q3 Results and Raised Guidance

Stock Track
·
Oct 30, 2025

Emergent BioSolutions Reports Strong Q3 2025 Results

TIPRANKS
·
Oct 30, 2025

Stock Track | Emergent BioSolutions Soars 17.02% as Q3 Results Beat Expectations and Company Raises Guidance

Stock Track
·
Oct 30, 2025

Stock Track | Emergent BioSolutions Soars 10.11% After-Hours on Strong Q3 Results and Positive Outlook

Stock Track
·
Oct 30, 2025

Stock Track | Emergent BioSolutions Soars 10.11% After Hours on Strong Q3 Results and Positive Outlook

Stock Track
·
Oct 30, 2025

Emergent BioSolutions Q3 revenue beats guidance, raises full-year outlook

Reuters
·
Oct 30, 2025

BRIEF-Emergent BioSolutions Q3 Revenue USD 231.1 Million

Reuters
·
Oct 30, 2025